Laronidase Completed Phase 4 Trials for Mucopolysaccharidosis Type I (MPS I) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT05134571China Post-marketing Surveillance (PMS) Study of Aldurazyme®